Allogene Therapeutics, Inc. (ALLO) Deferred Tax Assets, Investments

Allogene Therapeutics, Inc. Deferred Tax Assets, Investments

Allogene Therapeutics, Inc. (ALLO) had Deferred Tax Assets, Investments of $23.43 million as of 2025-12-31, per its 10-K filed 2026-03-12.

Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross

us-gaap:DeferredTaxAssetsInvestments · last filed 2026-03-12

• 2025-12-31: Deferred Tax Assets, Investments $23.43M.
• 2024-12-31: Deferred Tax Assets, Investments $26.01M.
• 2023-12-31: Deferred Tax Assets, Investments $28.73M.
• 2022-12-31: Deferred Tax Assets, Investments $26.29M; Deferred Tax Assets, Investments as first filed $5.44M.